From the analysis of the IMvigor 210 cohort in our study, we validated that the tight correlation between CD8+ T cell infiltration and expression level of ACSL4 contributed to the immune response in BLCA patients who underwent immunotherapy. Here, ACSL4 is linked to bladder transitional cell carcinoma.